These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6850545)

  • 1. Prospective evaluation of doxorubicin-induced cardiomyopathy resulting from postsurgical adjuvant treatment of patients with soft tissue sarcomas.
    Dresdale A; Bonow RO; Wesley R; Palmeri ST; Barr L; Mathison D; D'Angelo T; Rosenberg SA
    Cancer; 1983 Jul; 52(1):51-60. PubMed ID: 6850545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective study of cardiomyopathy induced by adjuvant doxorubicin therapy in patients with soft-tissue sarcomas.
    Ettinghausen SE; Bonow RO; Palmeri ST; Seipp CA; Steinberg SM; White DE; Rosenberg SA
    Arch Surg; 1986 Dec; 121(12):1445-51. PubMed ID: 3789915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial radionuclide assessment of doxorubicin cardiotoxicity in cancer patients with abnormal baseline resting left ventricular performance.
    Choi BW; Berger HJ; Schwartz PE; Alexander J; Wackers FJ; Gottschalk A; Zaret BL
    Am Heart J; 1983 Oct; 106(4 Pt 1):638-43. PubMed ID: 6613807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective evaluation of doxorubicin cardiotoxicity by rest and exercise radionuclide angiography.
    Palmeri ST; Bonow RO; Myers CE; Seipp C; Jenkins J; Green MV; Bacharach SL; Rosenberg SA
    Am J Cardiol; 1986 Sep; 58(7):607-13. PubMed ID: 3751931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective evaluation of cardiotoxicity during a six-hour doxorubicin infusion regimen in women with adenocarcinoma of the breast.
    Speyer JL; Green MD; Dubin N; Blum RH; Wernz JC; Roses D; Sanger J; Muggia FM
    Am J Med; 1985 Apr; 78(4):555-63. PubMed ID: 3838618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective randomized trial of adjuvant chemotherapy with bolus versus continuous infusion of doxorubicin in patients with high-grade extremity soft tissue sarcoma and an analysis of prognostic factors.
    Casper ES; Gaynor JJ; Hajdu SI; Magill GB; Tan C; Friedrich C; Brennan MF
    Cancer; 1991 Sep; 68(6):1221-9. PubMed ID: 1873773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of doxorubicin cardiotoxicity in patients with sarcomas by indium-111-antimyosin monoclonal antibody studies.
    Carrió I; Lopez-Pousa A; Estorch M; Duncker D; Berná L; Torres G; de Andrés L
    J Nucl Med; 1993 Sep; 34(9):1503-7. PubMed ID: 8355070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doxorubicin cardiotoxicity: response of left ventricular ejection fraction to exercise and incidence of regional wall motion abnormalities.
    Bae JH; Schwaiger M; Mandelkern M; Lin A; Schelbert HR
    Int J Card Imaging; 1988-1989; 3(4):193-201. PubMed ID: 3074127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective randomized study of the role of N-acetyl cysteine in reversing doxorubicin-induced cardiomyopathy.
    Dresdale AR; Barr LH; Bonow RO; Mathisen DJ; Myers CE; Schwartz DE; d'Angelo T; Rosenberg SA
    Am J Clin Oncol; 1982 Dec; 5(6):657-63. PubMed ID: 7165010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective randomized comparison of epirubicin and doxorubicin in patients with advanced breast cancer.
    Jain KK; Casper ES; Geller NL; Hakes TB; Kaufman RJ; Currie V; Schwartz W; Cassidy C; Petroni GR; Young CW
    J Clin Oncol; 1985 Jun; 3(6):818-26. PubMed ID: 3859587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy. Seven-year experience using serial radionuclide angiocardiography.
    Schwartz RG; McKenzie WB; Alexander J; Sager P; D'Souza A; Manatunga A; Schwartz PE; Berger HJ; Setaro J; Surkin L
    Am J Med; 1987 Jun; 82(6):1109-18. PubMed ID: 3605130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of radionuclide angiocardiography in the treatment of patients receiving doxorubicin-based chemotherapy: a reassessment.
    Dreicer R; Karwal MW; Midence G; Davis CS; Nettleman M
    Am J Clin Oncol; 1997 Apr; 20(2):132-7. PubMed ID: 9124185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gated blood pool scintigraphic monitoring of doxorubicin cardiomyopathy: comparison of camera and computerized probe results in 101 patients.
    Strashun AM; Goldsmith SJ; Horowitz SF
    J Am Coll Cardiol; 1986 Nov; 8(5):1082-7. PubMed ID: 3760382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-invasive monitoring of cardiac hemodynamic parameters in doxorubicin-treated patients: comparison with echocardiography.
    Villani F; Meazza R; Materazzo C
    Anticancer Res; 2006; 26(1B):797-801. PubMed ID: 16739356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doxorubicin cardiotoxicity: assessment of late left ventricular dysfunction by radionuclide cineangiography.
    Gottdiener JS; Mathisen DJ; Borer JS; Bonow RO; Myers CE; Barr LH; Schwartz DE; Bacharach SL; Green MV; Rosenberg SA
    Ann Intern Med; 1981 Apr; 94(4 pt 1):430-5. PubMed ID: 7212498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized trial of the cardioprotective agent ICRF-187 in pediatric sarcoma patients treated with doxorubicin.
    Wexler LH; Andrich MP; Venzon D; Berg SL; Weaver-McClure L; Chen CC; Dilsizian V; Avila N; Jarosinski P; Balis FM; Poplack DG; Horowitz ME
    J Clin Oncol; 1996 Feb; 14(2):362-72. PubMed ID: 8636745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late cardiotoxicity after treatment for a malignant bone tumor.
    Postma A; Bink-Boelkens MT; Beaufort-Krol GC; Kengen RA; Elzenga NJ; Schasfoort-van Leeuwen MJ; Schraffordt koops H; Kamps WA
    Med Pediatr Oncol; 1996 Apr; 26(4):230-7. PubMed ID: 8600333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective longitudinal evaluation of doxorubicin-induced cardiomyopathy in sarcoma patients: a report of the late effects surveillance system (LESS).
    Paulides M; Kremers A; Stöhr W; Bielack S; Jürgens H; Treuner J; Beck JD; Langer T;
    Pediatr Blood Cancer; 2006 Apr; 46(4):489-95. PubMed ID: 16333817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radionuclide ventriculography for evaluation and prevention of doxorubicin cardiotoxicity.
    Steinberg JS; Wasserman AG
    Clin Ther; 1985; 7(6):660-7. PubMed ID: 3907840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative regional chemotherapy and rapid-fraction irradiation for sarcomas of the soft tissue and bone.
    Denton JW; Dunham WK; Salter M; Urist MM; Balch CM
    Surg Gynecol Obstet; 1984 Jun; 158(6):545-51. PubMed ID: 6587604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.